SKNV in the News

Dermatology exam room where same-day procedures and office visits are performed

CMS Proposes Reimbursement Cuts for Same-Day Dermatology Procedures and SKNV Responds.

Graphic announcing SKNV's exclusive licensing agreement with Washington University (WashU) for Fluorouracil 5% and Calcipotriene 0.005% cream, featuring a bottle of Kefunova Cream alongside the SKNV and WashU logos.

SKNV Licenses Exclusive Rights to WashU’s Fluorouracil + Calcipotriene Patents

Kefunova Cream by SKNV - Fluorouracil 5% and Calcipotriene 0.005% topical treatment for actinic keratosis and superficial basal cell carcinoma

SKNV Launches Kefunova™, a Custom Formulated 5-FU Prescription Medication

4 Tips For Business Leaders To Innovate

Meet SKNV: The First Pharmacy for Sensitive Skin

SKNV’s Fran Malkin Co-Authors “Flip the Script” with Best-Selling Author and Negotiation Icon Chris Voss